AG
MDGL icon

Aperio Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

Aperio Group’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-26
Closed -$3K – 2570
2019
Q2 		$3K Buy
+26
New +$2.79K ﹤0.01% 2892
2015
Q3 		– Sell
-322
Closed -$25K – 1972
2015
Q2 		$25K Buy
+322
New +$27K ﹤0.01% 1996
2014
Q4 		– Sell
-357
Closed -$38K – 1896
2014
Q3 		$38K Buy
357
+19
+6% +$2.64K ﹤0.01% 1725
2014
Q2 		$48K Buy
+338
New +$49.4K ﹤0.01% 1712

Other funds holding MDGL

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return